People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
M.D. Anderson Cancer Center
Singlera Genomics Inc.
Hospices Civils de Lyon
University of California, San Francisco
Mina Alpha Limited
St. Louis University
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
University of California, Davis
Mayo Clinic
Columbia University
Rigshospitalet, Denmark
Chinese University of Hong Kong
Alexandria University
H. Lee Moffitt Cancer Center and Research Institute
Meridian Bioscience, Inc.
University Hospital, Grenoble
Medical University of Warsaw
University of Miami
Al-Azhar University
Target PharmaSolutions, Inc.
University of Texas Southwestern Medical Center
Karolinska Institutet
M.D. Anderson Cancer Center
Bayside Health
University of Texas Southwestern Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Arbor Research Collaborative for Health
Austral University, Argentina
Icahn School of Medicine at Mount Sinai
University of California, Irvine
Arbor Research Collaborative for Health
Hospices Civils de Lyon
Biotest Pharmaceuticals Corporation
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Gilead Sciences
Stanford University
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
University of Arkansas
Henry Ford Health System
Cairo University
Stanford University
University Hospital Freiburg